维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Badar J"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase 11, open label, randomized comparative trial of ondansetron alone versus the combination of ondansetron and aprepitant for the prevention of nausea and vomiting in patients with hematologic malignancies receiving regimens containing high-dose cytarabine 显示文摘	Badar T Cortes J Borthakur G	2015	Biomed Res Int2015，2015，49：	1
2	Updating temperature monitoring on reciprocating compressor connecting rods to improve reliability显示文摘	TOWNSEND J BADAR M SZEKERCES J	2015	Engineering Science and Technology an International Journal2015，19，1：	1
3	Pharmacodynamics and pharmacokinetics of the platelet GPⅡb/Ⅲa inhibitor tirofiban in patients undergoing percutaneous coronary intervention:implications for adjustment of tirofiban and clopidogrel dosage显示文摘	Kimmelstiel C Badar J Covic L		0，，：	1
4	Pharmacodynamiea and pharmacokinetic of the platelet GPⅡb/Ⅲa inhibitor tirofi-ban in patients undergoing percutaneous coronary intervention:inplictions for adjustment of tirofiban and dopidogrel doseage显示文摘	Badar J Covic L	2005	Thromb Rea2005，116，1：	1
5	Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects in patients with essential hypertension显示文摘	Panaza J A Casino P R Badar D M	1993	Circulation1993，87，5：	1
6	Pharmacodynamics and pharmacokinetics of the platelet GP Ⅱ b/Ⅲ a inhibitor tirofiban in patients undergoing percutaneous coronary intervention:implications for adjustment of tirofiban and clopidogrel dosage显示文摘	Kimmelstiel C Badar J Covic L	2005	Thromb Res2005，116，1：	1
7	Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis显示文摘	Leger AJ Jacques SL Badar J	2006	Circulation2006，113，9：	1
8	Pharmacodyhamics and phar- macokinetics of the platelet GP H b/III a inbibitor tirofiban in patients undergoing percutaneous coronary intervention:implications for adjust- ment of tirofiban and clop idogrel dosage 显示文摘	Kmmel Stiel C Badar J Covic L	2005	Thpomb Res2005，116，1：	1
9	Pharmacodynamics and pharmacokinetic of the platelet GPⅡb/Ⅲa inhibitor tirofiban in patients undergoing percutaneous coronary intervention:inplictions for adjustment of tirofiban and clopidogrel doseage显示文摘	Kimmelstiel C Badar J Covic L	2005	Thrombosis Research2005，116，：	1
10	Pharmacodynamics and pharmacokinetics of the platelet GPⅡb/Ⅲa inhibitor tirofiban in patients undergoing percutaneous coronary intervention:implications for adjustment of tirofiban and clopidogrel dosage显示文摘	Kimmelstiel C Badar J Covic L	2005	Thromb Res2005，116，1：	1
11	Pharmacodynamics and pharmacokinetics of the platelet GPIIb/IIla inhibitor tirofiban in pa- tients undergoing percutaneons coronary intervention : implications for adjustment of tirofiban and clopidogre/ dosage 显示文摘	Kimmelstiel C Badar J Covic L	2005	Thrombosis Research2005，116，8：	1
12	Pharmacodynamics and pharmacokinetics of the platelet GPI Ⅱb /Ⅲ a inhibitor tirofib an in patients undergoing percutaneous coronary intervention implicationsfor ad justmen t of tirofiban and clopidogrel dosage显示文摘	2]Kimmelstiel C Badar J Covic L	2005	Thromb Res2005，116，1：	1
13	Pharmaco-dynamics and phar- macokinetics of the platelet GPIIb/IIIa inhibitor tirofiban in patients undergoing percutaneous coronary intervention : implications for adjust- ment of tirofiban and clopidogrel dosage 显示文摘	Kimmelstiel C Badar J Covic L	2005	Thromb Res2005，1，：	1
14	Pharmacodynamics and pharmacokinetics of the platelet GP Ⅱb/Ⅲ a inhibitor tirofiban in patients undergoing percutaneous coronary intervention: implications for adjustment of tirofiban and clopidogrel dosage显示文摘	Kimmelstiel C Badar J Covic L	2005	Thromb Res2005，116，：	1
15	Pharmacodynamics and pharmacokinetics of the platelet GPⅡb/Ⅲa inhibitor tirofiban in patients undergoing percutaneous coronary intervention:implications for adjustment of tirofiban and clopidogrel dosage显示文摘	Kimmelstiel C Badar J Covic L	2005	Thromb Res2005，116，：	1
16	Pharmacodynamics and pharmacokinetics of the platelet GP Ⅱb/Ⅲa inhibitor tirofiban in patients undergoing percutaneous coronary intervention:implications for adjustment of tirofiban and clopidogrel dosage显示文摘	Kimmmelstie C Badar J Covic L	2005	Thromb Res2005，116，：	1
17	Pharmacodynamics and pharmacokinetics of the platelet GP Ⅱ b/Ⅲ a inhibitor tirofiban in patients undergoing percutaneous coronary intervention:implications for adjustment of tirofiban and clopidogrel dosage显示文摘	Kimmelstie IC Badar J Covic L	2005	Thromb Res2005，116，：	1
18	Pharmacodynamics and pharmacokinetics of the platelet GPⅡb/Ⅲa inhibitor tirofiban in patients undergoing pereutaneons coronary intervention:implications for adjustment of tirofiban and clopidogrel dosage显示文摘	KIMMELSTIEL C BADAR J COVIC L	2005	Thromb Res2005，5566，：	1
19	Interventricular lead separation is critical for NT-proBNP reduction after cardiac resynchronization ther- apy显示文摘	Lang NN Badar AA Pettit S J	2014	Biomark Med2014，8，6：	1
20	Pharmacodynamics and pharmacokinetics of the platelet GPIIb/III ainhibitor tirofiban in patients undergoing percutaneous coronary intervention:implications for adjustment of tirofiban and clop idogrel dosage显示文摘	Kmmel Stiel C Badar J Covic L	2005	Thromb Res2005，，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示